Elite Pharmaceuticals Inc (ELTP)

[WeeZuhl]

Revenues won't do anything for the stock.

It's all about our pipeline and the ART products.

Stock was trading at .40+ for an ENTIRE YEAR with HALF the annual revenue we're getting now.............What the F does that tell you?????

NOBODY CARES about revenue.

It's the pipeline and ART products!!!!!

I can't remember the last time I read such hooey. It's been a long time, probably the last time I read about how gaps mean anything. Share price above .30 was based on SequestOx NEWS, and when the news went bad, so did the share price. The pipeline is stocked more now than it was then, and the market just doesn't care. This company is not a NASDAQ darling trying to market a fancy new cancer drug with studies sponsored by Merck. This is a tiny, high-risk OTC niche generic manufacturer with a demonstrated history of failure. If they do get approval, generic Concerta and generic Adderall XR will dwarf SequestOx, but the market doesn't care about it until it happens. Nobody who matters gives a rat's ass about their pipeline (or even their approvals!). The SP will continue to go up and down based on this kind of news, but a sustained increase in share price will require a sustained increase in revenue.


Seems to me like NDA's aren't even worth the money or effort right now. Giant marketing risks are a given, but the hurdles the FDA makes a sponsor go through seem much more substantial for NDA's than for ANDA's. I love that generic Adderall was approved in almost exactly 10 months. Congrats to Nasrat and team, as they are getting really good at these ANDA's. Who would've thought a 10 month ANDA approval was possible? Even a few years ago when SequestOX was born, that was unheard of. I hope they keep submitting a new ANDA every quarter- not because of the news value but because that's how drug companies make money.